Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

Clinical trial NCT00704483 · COMPLETED

Trial details

NCT number: NCT00704483
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

Start date: 2008-07-01
Primary completion: 2010-08-01
Enrollment: 321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.